Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial

EJ Topol; JD Easton; P Amarenco; RM Califf; R Harrington; C Graffagnino; S Davis; HC Diener; J Ferguson; D Fitzgerald; A Shuaib; Peter Koudstaal; P Theroux; F van der Werf; JT Willerson; R Chan; R Samuels; B Ilson; J Granett

doi:10.1067/mhj.2000.105107

Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial

EJ Topol, JD Easton, P Amarenco, RM Califf, R Harrington, C Graffagnino, S Davis, HC Diener, J Ferguson, D Fitzgerald, A Shuaib, Peter Koudstaal, P Theroux, F van der Werf, JT Willerson, R Chan, R Samuels, B Ilson, J Granett

Neurology

Research output: Contribution to journal › Article › Academic › peer-review

72 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	927-933
Number of pages	7
Journal	American Heart Journal
Volume	139
DOIs	https://doi.org/10.1067/mhj.2000.105107
Publication status	Published - 2000

Research programs

EMC 05-02-44-04-01

Access to Document

10.1067/mhj.2000.105107

http://hdl.handle.net/1765/55828

Cite this

Topol, EJ., Easton, JD., Amarenco, P., Califf, RM., Harrington, R., Graffagnino, C., Davis, S., Diener, HC., Ferguson, J., Fitzgerald, D., Shuaib, A., Koudstaal, P., Theroux, P., van der Werf, F., Willerson, JT., Chan, R., Samuels, R., Ilson, B., & Granett, J. (2000). Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial. American Heart Journal, 139, 927-933. https://doi.org/10.1067/mhj.2000.105107

@article{66f8a380cb29452686429aa4a312cb22,

title = "Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial",

author = "EJ Topol and JD Easton and P Amarenco and RM Califf and R Harrington and C Graffagnino and S Davis and HC Diener and J Ferguson and D Fitzgerald and A Shuaib and Peter Koudstaal and P Theroux and {van der Werf}, F and JT Willerson and R Chan and R Samuels and B Ilson and J Granett",

year = "2000",

doi = "10.1067/mhj.2000.105107",

language = "Undefined/Unknown",

volume = "139",

pages = "927--933",

journal = "American Heart Journal",

issn = "0002-8703",

publisher = "Mosby Inc.",

}

Topol, EJ, Easton, JD, Amarenco, P, Califf, RM, Harrington, R, Graffagnino, C, Davis, S, Diener, HC, Ferguson, J, Fitzgerald, D, Shuaib, A, Koudstaal, P, Theroux, P, van der Werf, F, Willerson, JT, Chan, R, Samuels, R, Ilson, B & Granett, J 2000, 'Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial', American Heart Journal, vol. 139, pp. 927-933. https://doi.org/10.1067/mhj.2000.105107

TY - JOUR

T1 - Design of the blockade of the glycoprotein IIb/IIIa receptor to avoid vascular occlusion (BRAVO) trial

AU - Topol, EJ

AU - Easton, JD

AU - Amarenco, P

AU - Califf, RM

AU - Harrington, R

AU - Graffagnino, C

AU - Davis, S

AU - Diener, HC

AU - Ferguson, J

AU - Fitzgerald, D

AU - Shuaib, A

AU - Koudstaal, Peter

AU - Theroux, P

AU - van der Werf, F

AU - Willerson, JT

AU - Chan, R

AU - Samuels, R

AU - Ilson, B

AU - Granett, J

PY - 2000

Y1 - 2000

U2 - 10.1067/mhj.2000.105107

DO - 10.1067/mhj.2000.105107

M3 - Article

C2 - 10827369

SN - 0002-8703

VL - 139

SP - 927

EP - 933

JO - American Heart Journal

JF - American Heart Journal

ER -